EventsThe 1st International Electronic Conference on Pharmaceutics
Published
This submission belongs to the session G. Nanomedicine for Cancer of the event The 1st International Electronic Conference on Pharmaceutics
Published date
01 Dec, 2020
Citation
Maria Mendes, João Basso, João José Sousa, Alberto Pais, Carla Vitorino, Designing ultra-small nanostructured lipid carriers: critical process parameters, in Proceedings of The 1st International Electronic Conference on Pharmaceutics, 1 December–15 December 2020, MDPI: Basel, Switzerland, doi: 10.3390/IECP2020-08691
Share
Email
Facebook
Twitter
LinkedIn

Designing ultra-small nanostructured lipid carriers: critical process parameters

image
image
image
image
image
1. Centre for Neurosciences and Cell Biology (CNC), University of Coimbra, Faculty of Medicine, Rua Larga, Pólo I, 1st floor, 3004-504 Coimbra, Portugal, Portugal
2. Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
3. Coimbra Chemistry Centre, Department of Chemistry, University of Coimbra, Rua Larga, 3004-535 Coimbra, Portugal
4. Centre for Neurosciences and Cell Biology (CNC), University of Coimbra, Faculty of Medicine, Rua Larga, Pólo I, 1st floor, 3004-504 Coimbra, Portugal
Abstract

Nanoparticles (NPs) offer noteworthy advantages in the treatment of several diseases by prompting, among other beneficial actions, site‐specific delivery of drugs. Ultra-small nanostructured lipid carriers (usNLC) are no exception. These correspond to a class of NPs composed of a blend of solid and liquid lipids, the latter usually in a higher proportion, which promote a less ordered solid lipid matrix, providing a higher drug loading capacity, drug release modulation, and improved stability in comparison with other lipid nanoparticles. Several manufacturing methods have been described for obtaining usNLC. However, an in-depth process understanding is mandatory for a comprehensive knowledge allowing NLC property control.

In the present work, the hot high-pressure homogenization method, characterized by an easy scaling-up, simplicity, and ease of handling, is used to develop highly concentrated, small-sized NLCs.

Critical process parameters (CPPs) and critical material attributes (CMAs) are assessed to address the reproducibility of the manufacturing procedure, consistency among batches, long-term stability of the formulation, drug loading capacity and drug release.

In order to acquire an enhanced understanding of this method, a multivariable analysis is herein applied to inspect how the physicochemical properties of the usNLC were influenced by the variation of CPPs. These include HPH-time, HPH-pressure, while CMAs, such as lipid concentration, are also taken into consideration. The results show that a high lipid concentration (15% w/w), with an intermediate pressure and a short time in HPH seem to be the crucial parameters for obtaining both a small particle size (<100nm) and a narrow size distribution (polydispersity index <0.2) in usNLC prepared by the hot-HPH method, without affecting zeta potential (>|30 mV|).

Keywords
ultra-small nanostructured lipid carriers
cancer
nanoparticles
critical process parameters
critical material attributes
Manuscript
Cyclodextrin-efavirenz complexes investigated by solid state and dissolution studies
Biological studies on cyclodextrins